NSCLC STAGE IV
Clinical trials for NSCLC STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE IV trials appear
Sign up with your email to follow new studies for NSCLC STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can extra immunotherapy stall advanced lung cancer?
Disease control OngoingThis phase 2 trial tests whether continuing the immunotherapy drug cemiplimab for up to a year after initial treatment can delay cancer growth in people with stage IV non-small cell lung cancer that has spread to only a few places (oligometastatic). About 136 participants will be…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for elderly lung cancer patients: targeted pill shows promise
Disease control OngoingThis study tests a daily pill called adagrasib in 68 patients with a specific type of advanced lung cancer (KRAS G12C mutation) who are either 70 or older or have poor physical health. The goal is to see if the drug can shrink tumors or stop them from growing. Patients take the m…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Blood test may predict lung cancer drug success
Disease control OngoingThis study looks at whether a blood test (liquid biopsy) can help doctors see how well the drug brigatinib is working in people with a certain type of advanced lung cancer (ALK-positive NSCLC). About 33 patients who have not had chemotherapy before will take brigatinib pills dail…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a precise radiation burst stall Cancer's spread?
Disease control OngoingThis study tests whether giving stereotactic body radiotherapy (SBRT) to growing metastatic tumors can delay overall cancer progression. About 107 adults with triple-negative breast cancer or non-small cell lung cancer that has started to grow in a few spots will receive SBRT or …
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Blood test may guide lung cancer therapy, avoiding unnecessary chemo
Disease control OngoingThis study is testing whether a blood test that looks for cancer DNA can tell if immunotherapy alone is working for people with advanced non-small cell lung cancer. If the test shows the cancer is not responding, patients would switch to immunotherapy plus chemotherapy. The goal …
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Julia K. Rotow, MD • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC